Ardelyx Inc (ARDX NASDAQ) stock market data APIs
$4.2238
-0.32(-7.6%)
as of July 2, 2025
Try our APIs with
free plan!
Ardelyx Inc Financial Data Overview
Price chart is built with
Anychart
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Prev. Close
4.2238
Open
3.9075
High
4.334
Low
3.9075
52 wk Range
3.21-7.18
Market Cap
933 M
Shares Outstanding
239 M
Revenue
362 M
EPS
-0.17
Beta
0.592
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Ardelyx Inc data using free add-ons & libraries
Get Ardelyx Inc Fundamental Data
Ardelyx Inc Fundamental data includes:
- Net Revenue: 362 M
- EBITDA: -37 391 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-30
- EPS/Forecast: -0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ardelyx Inc News
New
Ardelyx spike attributed to Xphozah legal update
Alexander Sikov Ardelyx (NASDAQ:ARDX [https://seekingalpha.com/symbol/ARDX]) shares rose ~9% on Wednesday, a move Jefferies attributed to a major update related to the company's ongoing legal battle ...
Exploring 3 High Growth Tech Stocks In The US Market
The United States market has shown a positive trajectory, climbing 2.9% in the last week and up 14% over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this c...
High Growth Tech Stocks in US Market to Watch
In the current U.S. market landscape, major indices like the S&P 500 and Nasdaq have experienced fluctuations with recent slips following record highs, particularly as tech stocks face downward pressu...
US High Growth Tech Stocks with Promising Potential
The United States market has shown robust performance recently, climbing 3.4% in the last 7 days and rising 14% over the past year, with earnings forecast to grow by 15% annually. In this thriving env...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
